Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,230 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Analysis of perioperative clinical features and complications after orthopaedic surgery in rheumatoid arthritis patients treated with tocilizumab in a real-world setting: results from the multicentre TOcilizumab in Perioperative Period (TOPP) study.
Momohara S, Hashimoto J, Tsuboi H, Miyahara H, Nakagawa N, Kaneko A, Kondo N, Matsuno H, Wada T, Nonaka T, Kanbe K, Takagi H, Murasawa A, Matsubara T, Suguro T. Momohara S, et al. Among authors: matsubara t. Mod Rheumatol. 2013 May;23(3):440-9. doi: 10.1007/s10165-012-0683-0. Epub 2012 Jun 10. Mod Rheumatol. 2013. PMID: 22684398
Risk of postoperative complications in rheumatoid arthritis relevant to treatment with biologic agents: a report from the Committee on Arthritis of the Japanese Orthopaedic Association.
Suzuki M, Nishida K, Soen S, Oda H, Inoue H, Kaneko A, Takagishi K, Tanaka T, Matsubara T, Mitsugi N, Mochida Y, Momohara S, Mori T, Suguro T. Suzuki M, et al. Among authors: matsubara t. J Orthop Sci. 2011 Nov;16(6):778-84. doi: 10.1007/s00776-011-0142-3. Epub 2011 Aug 27. J Orthop Sci. 2011. PMID: 21874335
Meta-analysis identifies nine new loci associated with rheumatoid arthritis in the Japanese population.
Okada Y, Terao C, Ikari K, Kochi Y, Ohmura K, Suzuki A, Kawaguchi T, Stahl EA, Kurreeman FA, Nishida N, Ohmiya H, Myouzen K, Takahashi M, Sawada T, Nishioka Y, Yukioka M, Matsubara T, Wakitani S, Teshima R, Tohma S, Takasugi K, Shimada K, Murasawa A, Honjo S, Matsuo K, Tanaka H, Tajima K, Suzuki T, Iwamoto T, Kawamura Y, Tanii H, Okazaki Y, Sasaki T, Gregersen PK, Padyukov L, Worthington J, Siminovitch KA, Lathrop M, Taniguchi A, Takahashi A, Tokunaga K, Kubo M, Nakamura Y, Kamatani N, Mimori T, Plenge RM, Yamanaka H, Momohara S, Yamada R, Matsuda F, Yamamoto K. Okada Y, et al. Among authors: matsubara t. Nat Genet. 2012 Mar 25;44(5):511-6. doi: 10.1038/ng.2231. Nat Genet. 2012. PMID: 22446963
Incidence and aggravation of cervical spine instabilities in rheumatoid arthritis: a prospective minimum 5-year follow-up study of patients initially without cervical involvement.
Yurube T, Sumi M, Nishida K, Miyamoto H, Kohyama K, Matsubara T, Miura Y, Sugiyama D, Doita M; Kobe Spine Conference. Yurube T, et al. Among authors: matsubara t. Spine (Phila Pa 1976). 2012 Dec 15;37(26):2136-44. doi: 10.1097/BRS.0b013e31826def1c. Spine (Phila Pa 1976). 2012. PMID: 22895480
Adalimumab, a human anti-TNF monoclonal antibody, outcome study for the prevention of joint damage in Japanese patients with early rheumatoid arthritis: the HOPEFUL 1 study.
Takeuchi T, Yamanaka H, Ishiguro N, Miyasaka N, Mukai M, Matsubara T, Uchida S, Akama H, Kupper H, Arora V, Tanaka Y. Takeuchi T, et al. Among authors: matsubara t. Ann Rheum Dis. 2014 Mar;73(3):536-43. doi: 10.1136/annrheumdis-2012-202433. Epub 2013 Jan 11. Ann Rheum Dis. 2014. PMID: 23316080 Free PMC article. Clinical Trial.
Phase III study of the efficacy and safety of subcutaneous versus intravenous tocilizumab monotherapy in patients with rheumatoid arthritis.
Ogata A, Tanimura K, Sugimoto T, Inoue H, Urata Y, Matsubara T, Kondo M, Ueki Y, Iwahashi M, Tohma S, Ohta S, Saeki Y, Tanaka T; Musashi Study Investigators. Ogata A, et al. Among authors: matsubara t. Arthritis Care Res (Hoboken). 2014 Mar;66(3):344-54. doi: 10.1002/acr.22110. Arthritis Care Res (Hoboken). 2014. PMID: 23983039 Free PMC article. Clinical Trial.
Drug free REmission/low disease activity after cessation of tocilizumab (Actemra) Monotherapy (DREAM) study.
Nishimoto N, Amano K, Hirabayashi Y, Horiuchi T, Ishii T, Iwahashi M, Iwamoto M, Kohsaka H, Kondo M, Matsubara T, Mimura T, Miyahara H, Ohta S, Saeki Y, Saito K, Sano H, Takasugi K, Takeuchi T, Tohma S, Tsuru T, Ueki Y, Yamana J, Hashimoto J, Matsutani T, Murakami M, Takagi N. Nishimoto N, et al. Among authors: matsubara t. Mod Rheumatol. 2014 Jan;24(1):17-25. doi: 10.3109/14397595.2013.854079. Mod Rheumatol. 2014. PMID: 24261754 Free article.
Retreatment efficacy and safety of tocilizumab in patients with rheumatoid arthritis in recurrence (RESTORE) study.
Nishimoto N, Amano K, Hirabayashi Y, Horiuchi T, Ishii T, Iwahashi M, Iwamoto M, Kohsaka H, Kondo M, Matsubara T, Mimura T, Miyahara H, Ohta S, Saeki Y, Saito K, Sano H, Takasugi K, Takeuchi T, Tohma S, Tsuru T, Ueki Y, Yamana J, Hashimoto J, Matsutani T, Murakami M, Takagi N. Nishimoto N, et al. Among authors: matsubara t. Mod Rheumatol. 2014 Jan;24(1):26-32. doi: 10.3109/14397595.2013.854080. Mod Rheumatol. 2014. PMID: 24261755 Free article.
2,230 results